Cue Biopharma, Inc.

CUE

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001645460

SEC filings (opens in a new tab)

In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Cue Biopharma, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of CUE: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Q1 2023	Change
Holders	61	63	+2
Shares	12.8M	12.1M	−705.9K (−5.5%)
Value	$36.4M	$43.0M	+$6.67M (+18.3%)

New holders (11)

Institutions that held Cue Biopharma, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to CUE in Q1 2023
Institution	Shares	Value	% of portfolio
Susquehanna International Group, LLP	132,535	$473.1K	0.00%
HighTower Advisors, LLC	76,110	$272.0K	0.00%
Channel Wealth LLC	60,050	$214.4K	0.14%
Jane Street Group, LLC	26,974	$96.3K	0.00%
Squarepoint Ops LLC	20,233	$72.2K	0.00%
ETF Managers Group, LLC	13,528	$48.3K	0.00%
Simplex Trading, LLC	11,586	$41.0K	0.00%
Group One Trading, L.P.	1,578	$5.63K	0.00%
Point72 Middle East FZE	646	$2.31K	0.00%
Johnson Midwest Financial, LLC	300	$1.07K	0.00%
Sunbelt Securities, Inc.	237	$839	0.00%

Sold out (9)

Institutions that held Cue Biopharma, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of CUE in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Jacobs Levy Equity Management, Inc	69,522	$198.1K
Sanders Morris Harris LLC	56,420	$160.8K
Acadian Asset Management LLC	37,167	$104.0K
Bank of Montreal	33,900	$98.0K
Qube Research & Technologies Ltd	28,797	$82.1K
Connor, Clark & Lunn Investment Management Ltd.	22,970	$65.5K
Jump Financial, LLC	11,627	$33.1K
Accurate Wealth Management, LLC	2,550	$7.60K
Money Concepts Capital Corp	715	$2.04K